2021
DOI: 10.1097/01.ccm.0000808080.47792.e1
|View full text |Cite
|
Sign up to set email alerts
|

439: Iron Overload Cardiomyopathy: A Progressive Silent Disease Leading to End-Stage Heart Failure

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…End-stage heart failure due to iron overload cardiomyopathy (end-stage cardiac hemochromatosis) was reported in the literature. It developed following long-term transfusions in patients with DBA [ 15 , 35 ]. Some key features of end-stage cardiac hemochromatosis included dilated cardiomyopathy, severe biventricular systolic disfunction, supraventricular and ventricular arrhythmias, as well as cardiogenic shock [ 15 ].…”
Section: Discussionmentioning
confidence: 99%
“…End-stage heart failure due to iron overload cardiomyopathy (end-stage cardiac hemochromatosis) was reported in the literature. It developed following long-term transfusions in patients with DBA [ 15 , 35 ]. Some key features of end-stage cardiac hemochromatosis included dilated cardiomyopathy, severe biventricular systolic disfunction, supraventricular and ventricular arrhythmias, as well as cardiogenic shock [ 15 ].…”
Section: Discussionmentioning
confidence: 99%